RESPONSE AFTER NON-FINAL ACTION - ENTERED
final action
on 12 Jun 2024
Last Applicant/ Owned by
Building 200, Suite 001
Cambridge
MA
02139
Serial Number
98211025 filed on 05th Oct 2023
Registration Number
N/A
Correspondent Address
Joyce Liou MORRISON & FOERSTER LLP
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
PASSKEY
Research and development services in the field of pharmaceuticals Pharmaceuticals for the treatment of cancer, immunological diseases, metabolic diseases, and neurodegenerative diseases
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Research and development services in the field of pharmaceuticals
First Use Date in General
11th 000101
First Use Date in Commerce
11th 000101
Class [005]
Pharmaceutical Products
Pharmaceuticals for the treatment of cancer, immunological diseases, metabolic diseases, and neurodegenerative diseases
First Use Date in General
11th 000101
First Use Date in Commerce
11th 000101
Mark Details
Serial Number
No 98211025
Mark Type
No Service Mark
Attorney Docket Number
No 275766001000
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 12th Jun 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 12th Jun 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 12th Jun 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 25th May 2024 | NON-FINAL ACTION E-MAILED |
| 25th May 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 25th May 2024 | ASSIGNED TO EXAMINER |
| 25th May 2024 | NON-FINAL ACTION WRITTEN |
| 14th Oct 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| 09th Oct 2023 | NEW APPLICATION ENTERED |